There has been a growing interest in vascular impairment associated with Alzheimer's disease (AD). This interest was stimulated by the findings of higher incidence of vascular risk factors in AD. Signs of vascular impairment were investigated notably in the field of imaging methods. Our aim was to explore ultrasonographic studies of extra- and intracranial vessels in patients with AD and mild cognitive impairment (MCI) and define implications for diagnosis, treatment, and prevention of the disease. The most frequently studied parameters with extracranial ultrasound are intima-media thickness in common carotid artery, carotid atherosclerosis, and total cerebral blood flow. The transcranial ultrasound concentrates mostly on flow velocities, pulsatility indices, cerebrovascular reserve capacity, and cerebral microembolization. Studies suggest that there is morphological and functional impairment of cerebral circulation in AD compared to healthy subjects. Ultrasound as a non-invasive method could be potentially useful in identifying individuals in a higher risk of progression of cognitive decline.

Department of Neurology 2nd Faculty of Medicine Motol University Hospital Charles University Prague Czech Republic

Department of Neurology 2nd Faculty of Medicine Motol University Hospital Charles University Prague Czech Republic ; International Clinical Research Center St Anne's University Hospital Brno Czech Republic

Department of Neurology International Clinical Research Center St Anne's University Hospital Brno Czech Republic

Department of Neurosurgery 1st Faculty of Medicine Central Military Hospital Charles University Prague Czech Republic ; International Clinical Research Center St Anne's University Hospital Brno Czech Republic

Zobrazit více v PubMed

Albayrak R., Yaman M., Uslan I., Degirmenci B., Acar M., Haktanir A. (2006). Evaluation of total cerebral blood flow volume in cerebral atrophy. Neurosci. Lett. 399, 124–12810.1016/j.neulet.2006.01.039 PubMed DOI

Asil T., Uzuner N. (2005). Differentiation of vascular dementia and Alzheimer disease: a functional transcranial Doppler ultrasonographic study. J. Ultrasound Med. 24, 1065–1070 PubMed

Balestrini S., Perozzi C., Altamura C., Vernieri F., Luzzi S., Bartolini M., et al. (2013). Severe carotid stenosis and impaired cerebral hemodynamics can influence cognitive deterioration. Neurology 80, 2145–215010.1212/WNL.0b013e318295d71a PubMed DOI

Balucani C., Viticchi G., Falsetti L., Silvestrini M. (2012). Cerebral hemodynamics and cognitive performance in bilateral asymptomatic carotid stenosis. Neurology 79, 1788–179510.1212/WNL.0b013e318270402e PubMed DOI

Bar K. J., Boettger M. K., Seidler N., Mentzel H. J., Terborg C., Sauer H. (2007). Influence of galantamine on vasomotor reactivity in Alzheimer’s disease and vascular dementia due to cerebral microangiopathy. Stroke 38, 3186–319210.1161/STROKEAHA.107.492033 PubMed DOI

Bishop C. C., Powell S., Rutt D., Browse N. L. (1986). Transcranial Doppler measurement of middle cerebral artery blood flow velocity: a validation study. Stroke 17, 913–91510.1161/01.STR.17.5.913 PubMed DOI

Bonte F. J., Devous M. D., Sr., Reisch J. S., Ajmani A. K., Weiner M. F., Hom J., et al. (1989). The effect of acetazolamide on regional cerebral blood flow in patients with Alzheimer’s disease or stroke as measured by single-photon emission computed tomography. Invest. Radiol. 24, 99–10310.1097/00004424-198902000-00002 PubMed DOI

Breteler M. M. (2000). Vascular risk factors for Alzheimer’s disease: an epidemiologic perspective. Neurobiol. Aging 21, 153–16010.1016/S0197-4580(99)00110-4 PubMed DOI

Breteler M. M., van Swieten J. C., Bots M. L., Grobbee D. E., Claus J. J., van den Hout J. H., et al. (1994). Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 44, 1246–125210.1212/WNL.44.7.1246 PubMed DOI

Caamano J., Gomez M. J., Cacabelos R. (1993). Transcranial Doppler ultrasonography in senile dementia: neuropsychological correlations. Methods Find. Exp. Clin. Pharmacol. 15, 193–199 PubMed

Casserly I., Topol E. (2004). Convergence of atherosclerosis and Alzheimer’s disease: inflammation, cholesterol, and misfolded proteins. Lancet 363, 1139–114610.1016/S0140-6736(04)15900-X PubMed DOI

Chang X. L., Zhou H. Q., Lei C. Y., Wu B., Chen Y. C., Hao Z. L., et al. (2013). Association between asymptomatic carotid stenosis and cognitive function: a systematic review. Neurosci. Biobehav. Rev. 37, 1493–149910.1016/j.neubiorev.2013.05.011 PubMed DOI

Claassen J. A., Diaz-Arrastia R., Martin-Cook K., Levine B. D., Zhang R. (2009). Altered cerebral hemodynamics in early Alzheimer disease: a pilot study using transcranial Doppler. J. Alzheimers Dis. 17, 621–62910.3233/JAD-2009-1079 PubMed DOI PMC

Dahl A., Lindegaard K. F., Russell D., Nyberg-Hansen R., Rootwelt K., Sorteberg W., et al. (1992). A comparison of transcranial Doppler and cerebral blood flow studies to assess cerebral vasoreactivity. Stroke 23, 15–1910.1161/01.STR.23.1.15 PubMed DOI

de la Sierra A., Zamorano J. L., Ruilope L. M. (2009). Application of hypertension guidelines in clinical practice: implementation of the 2007 ESH/ESC European practice Guidelines in Spain. J. Hypertens. Suppl. 27, S27–S3210.1097/01.hjh.0000356769.32130.95 PubMed DOI

de la Torre J. C. (2010). The vascular hypothesis of Alzheimer’s disease: bench to bedside and beyond. Neurodegener. Dis. 7, 116–12110.1159/000285520 PubMed DOI

DeCarli C., Miller B. L., Swan G. E., Reed T., Wolf P. A., Carmelli D. (2001). Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch. Neurol. 58, 643–64710.1001/archneur.58.4.643 PubMed DOI

DeKosky S. T., Shih W. J., Schmitt F. A., Coupal J., Kirkpatrick C. (1990). Assessing utility of single photon emission computed tomography (SPECT) scan in Alzheimer disease: correlation with cognitive severity. Alzheimer Dis. Assoc. Disord. 4, 14–2310.1097/00002093-199040100-00002 PubMed DOI

Demarin V., Zavoreo I., Kes V. B. (2012). Carotid artery disease and cognitive impairment. J. Neurol. Sci. 322, 107–11110.1016/j.jns.2012.07.008 PubMed DOI

Di Tullio M., Sacco R. L., Venketasubramanian N., Sherman D., Mohr J. P., Homma S. (1993). Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke 24, 1020–102410.1161/01.STR.24.7.1020 PubMed DOI

Doepp F., Valdueza J. M., Schreiber S. J. (2006). Transcranial and extracranial ultrasound assessment of cerebral hemodynamics in vascular and Alzheimer’s dementia. Neurol. Res. 28, 645–64910.1179/016164106X130380 PubMed DOI

Dogan S., Duivenvoorden R., Grobbee D. E., Kastelein J. J., Shear C. L., Evans G. W., et al. (2010). Ultrasound protocols to measure carotid intima-media thickness in trials; comparison of reproducibility, rate of progression, and effect of intervention in subjects with familial hypercholesterolemia and subjects with mixed dyslipidemia. Ann. Med. 42, 447–46410.3109/07853890.2010.499132 PubMed DOI

Dorfler P., Puls I., Schliesser M., Maurer M., Becker G. (2000). Measurement of cerebral blood flow volume by extracranial sonography. J. Cereb. Blood Flow Metab. 20, 269–27110.1097/00004647-200002000-00007 PubMed DOI

Droste D. W., Reisener M., Kemeny V., Dittrich R., Schulte-Altedorneburg G., Stypmann J., et al. (1999). Contrast transcranial Doppler ultrasound in the detection of right-to-left shunts. Stroke 30, 1014–101810.1161/01.STR.30.5.1014 PubMed DOI

Gaudet J. G., Meyers P. M., McKinsey J. F., Lavine S. D., Gray W., Mitchell E., et al. (2009). Incidence of moderate to severe cognitive dysfunction in patients treated with carotid artery stenting. Neurosurgery 65, 325–329 discussion 9–30,10.1227/01.NEU.0000349920.69637.78 PubMed DOI PMC

Ghorbani A., Chitsaz A., Shishegar M., Akbari M. (2010). Evaluation of the effect of donepezil on cerebral blood flow velocity in Alzheimer’s disease. Neurosciences (Riyadh) 15, 172–176 PubMed

Gill R. W. (1985). Measurement of blood flow by ultrasound: accuracy and sources of error. Ultrasound Med. Biol. 11, 625–64110.1016/0301-5629(85)90035-3 PubMed DOI

Glodzik L., Randall C., Rusinek H., de Leon M. J. (2013). Cerebrovascular reactivity to carbon dioxide in Alzheimer’s disease. J. Alzheimers Dis. 35, 427–44010.3233/JAD-122011 PubMed DOI PMC

Gonzalez J., Wood J. C., Dorey F. J., Wren T. A., Gilsanz V. (2008). Reproducibility of carotid intima-media thickness measurements in young adults. Radiology 247, 465–47110.1148/radiol.2472070691 PubMed DOI

Gorelick P. B. (2004). Risk factors for vascular dementia and Alzheimer disease. Stroke 35, 2620–262210.1161/01.STR.0000143318.70292.47 PubMed DOI

Grant E. G., Benson C. B., Moneta G. L., Alexandrov A. V., Baker J. D., Bluth E. I., et al. (2003). Carotid artery stenosis: gray-scale and Doppler US diagnosis – Society of Radiologists in Ultrasound Consensus Conference. Radiology 229, 340–34610.1148/radiol.2292030516 PubMed DOI

Greco G., Egorova N. N., Moskowitz A. J., Gelijns A. C., Kent K. C., Manganaro A. J., et al. (2013). Model for predicting the risk of carotid artery disease. Ann. Surg. 257, 1168–117310.1097/SLA.0b013e31827b9761 PubMed DOI

Greenland P., Alpert J. S., Beller G. A., Benjamin E. J., Budoff M. J., Fayad Z. A., et al. (2010). 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 56, e50–e10310.1016/j.jacc.2010.09.001 PubMed DOI

Gucuyener D. O., Yenilmez C., Ayranci U., Ozdemir F., Uzuner N., Ozkan S., et al. (2010). An analysis of changes in cerebral blood flood velocities in depressive pseudo-dementia and Alzheimer disease patients. Neurologist 16, 358–36310.1097/NRL.0b013e3181a2eace PubMed DOI

Gusti S. I., Coteanu M. I., Gusti A. S. (2004). Study of the cerebral vascular Doppler velocimetry and EEG in a group of 18 cases of Alzheimer’s disease. Rom. J. Physiol. 41, 91–97 PubMed

Hara H., Virmani R., Ladich E., Mackey-Bojack S., Titus J., Reisman M., et al. (2005). Patent foramen ovale: current pathology, pathophysiology, and clinical status. J. Am. Coll. Cardiol. 46, 1768–177610.1016/j.jacc.2005.08.038 PubMed DOI

Hofman A., Ott A., Breteler M. M., Bots M. L., Slooter A. J., van Harskamp F., et al. (1997). Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet 349, 151–15410.1016/S0140-6736(96)09328-2 PubMed DOI

Jagust W. J., Eberling J. L., Reed B. R., Mathis C. A., Budinger T. F. (1997). Clinical studies of cerebral blood flow in Alzheimer’s disease. Ann. N. Y. Acad. Sci. 826, 254–26210.1111/j.1749-6632.1997.tb48477.x PubMed DOI

Jauss M., Kaps M., Keberle M., Haberbosch W., Dorndorf W. (1994). A comparison of transesophageal echocardiography and transcranial Doppler sonography with contrast medium for detection of patent foramen ovale. Stroke 25, 1265–126710.1161/01.STR.25.6.1265 PubMed DOI

Job F. P., Ringelstein E. B., Grafen Y., Flachskampf F. A., Doherty C., Stockmanns A., et al. (1994). Comparison of transcranial contrast Doppler sonography and transesophageal contrast echocardiography for the detection of patent foramen ovale in young stroke patients. Am. J. Cardiol. 74, 381–38410.1016/0002-9149(94)90407-3 PubMed DOI

Johnson K. A., Jones K., Holman B. L., Becker J. A., Spiers P. A., Satlin A., et al. (1998). Preclinical prediction of Alzheimer’s disease using SPECT. Neurology 50, 1563–157110.1212/WNL.50.6.1563 PubMed DOI

Johnston S. C., O’Meara E. S., Manolio T. A., Lefkowitz D., O’Leary D. H., Goldstein S., et al. (2004). Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann. Intern. Med. 140, 237–24710.7326/0003-4819-140-4-200402170-00005 PubMed DOI

Kalaria R. (2002). Similarities between Alzheimer’s disease and vascular dementia. J. Neurol. Sci. 203-204, 29–3410.1016/S0022-510X(02)00256-3 PubMed DOI

Knapp W. H., Dannenberg C., Marschall B., Zedlick D., Loschmann K., Bettin S., et al. (1996). Changes in local cerebral blood flow by neuroactivation and vasoactivation in patients with impaired cognitive function. Eur. J. Nucl. Med. 23, 878–88810.1007/BF01084360 PubMed DOI

Kuwabara Y., Ichiya Y., Otsuka M., Masuda K., Ichimiya A., Fujishima M. (1992). Cerebrovascular responsiveness to hypercapnia in Alzheimer’s dementia and vascular dementia of the Binswanger type. Stroke 23, 594–59810.1161/01.STR.23.4.594 PubMed DOI

Lee S. T., Jung K. H., Lee Y. S. (2007). Decreased vasomotor reactivity in Alzheimer’s disease. J. Clin. Neurol. 3, 18–2310.3988/jcn.2007.3.1.18 PubMed DOI PMC

Likitjaroen Y., Suwanwela N. C., Phanthumchinda K. (2009). Vasoreactivity induced by acetazolamide in patients with vascular dementia versus Alzheimer’s disease. J. Neurol. Sci. 283, 32–3510.1016/j.jns.2009.02.363 PubMed DOI

Lorenz M. W., Markus H. S., Bots M. L., Rosvall M., Sitzer M. (2007). Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115, 459–46710.1161/CIRCULATIONAHA.106.628875 PubMed DOI

Maalikjy Akkawi N., Borroni B., Agosti C., Pezzini A., Magoni M., Rozzini L., et al. (2003). Volume reduction in cerebral blood flow in patients with Alzheimer’s disease: a sonographic study. Dement. Geriatr. Cogn. Disord. 16, 163–16910.1159/000071005 PubMed DOI

Markus H. S., Harrison M. J. (1992). Estimation of cerebrovascular reactivity using transcranial Doppler, including the use of breath-holding as the vasodilatory stimulus. Stroke 23, 668–67310.1161/01.STR.23.5.668 PubMed DOI

Matsuda H. (2007). Role of neuroimaging in Alzheimer’s disease, with emphasis on brain perfusion SPECT. J. Nucl. Med. 48, 1289–130010.2967/jnumed.106.037218 PubMed DOI

Matteis M., Silvestrini M., Troisi E., Bragoni M., Vernieri F., Caltagirone C. (1998). Cerebral hemodynamic patterns during stimuli tasks in multi-infarct and Alzheimer types of dementia. Acta Neurol. Scand. 97, 374–38010.1111/j.1600-0404.1998.tb05969.x PubMed DOI

McMahon C. J., McDermott P., Horsfall D., Selvarajah J. R., King A. T., Vail A. (2007). The reproducibility of transcranial Doppler middle cerebral artery velocity measurements: implications for clinical practice. Br. J. Neurosurg. 21, 21–2710.1080/02688690701210539 PubMed DOI

Menendez-Gonzalez M., Garcia-Garcia J., Calleja S., Rojo J., Ribacoba R. (2011). Vasomotor reactivity is similarly impaired in patients with Alzheimer’s disease and patients with amyloid hemorrhage. J. Neuroimaging 21, e83–e8510.1111/j.1552-6569.2009.00438.x PubMed DOI

Modrego P. J., Rios C., Perez Trullen J. M., Errea J. M., Garcia-Gomara M. J., Sanchez S. (2008). The cerebrovascular pathology in Alzheimer’s disease and its influence on clinical variables. Am. J. Alzheimers Dis. Other Demen. 23, 91–9610.1177/1533317507309274 PubMed DOI PMC

Modrego P. J., Rios C., Perez Trullen J. M., Garcia-Gomara M. J., Errea J. M. (2009). Carotid intima-media thickness as a predictor of response to cholinesterase inhibitors in Alzheimer’s disease: an open-label trial. CNS Drugs 23, 253–26010.2165/00023210-200923030-00006 PubMed DOI

Mohler E. R., III, Gornik H. L., Gerhard-Herman M., Misra S., Olin J. W., Zierler E. (2012). ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS 2012 appropriate use criteria for peripheral vascular ultrasound and physiological testing part I: arterial ultrasound and physiological testing: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American College of Radiology, American Institute of Ultrasound in Medicine, American Society of Echocardiography, American Society of Nephrology, Intersocietal Commission for the Accreditation of Vascular Laboratories, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. J. Vasc. Surg. 56, e17–e5110.1016/j.jvs.2012.05.054 PubMed DOI PMC

Morovic S., Jurasic M. J., Martinic Popovic I., Seric V., Lisak M., Demarin V. (2009). Vascular characteristics of patients with dementia. J. Neurol. Sci. 283, 41–4310.1016/j.jns.2009.02.330 PubMed DOI

Muller M., Voges M., Piepgras U., Schimrigk K. (1995). Assessment of cerebral vasomotor reactivity by transcranial Doppler ultrasound and breath-holding. Stroke 26, 96–100 PubMed

National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143–3421 PubMed

Nemec J. J., Marwick T. H., Lorig R. J., Davison M. B., Chimowitz M. I., Litowitz H., et al. (1991). Comparison of transcranial Doppler ultrasound and transesophageal contrast echocardiography in the detection of interatrial right-to-left shunts. Am. J. Cardiol. 68, 1498–150210.1016/0002-9149(91)90285-S PubMed DOI

Oishi M., Mochizuki Y., Takasu T. (1999). Regional differences in cerebrovascular reactivity to acetazolamide in Alzheimer’s disease. J. Clin. Neurosci. 6, 380–38110.1054/jocn.1997.0085 PubMed DOI

Oka F., Ishihara H., Kato S., Oku T., Yamane A., Kunitugu I., et al. (2013). Cerebral hemodynamic benefits after carotid artery stenting in patients with near occlusion. J. Vasc. Surg. 58, 1512–151710.1016/j.jvs.2013.05.103 PubMed DOI

Pavics L., Grunwald F., Reichmann K., Horn R., Kitschenberg A., Hartmann A., et al. (1999). Regional cerebral blood flow single-photon emission tomography with 99mTc-HMPAO and the acetazolamide test in the evaluation of vascular and Alzheimer’s dementia. Eur. J. Nucl. Med. 26, 239–24510.1007/s002590050383 PubMed DOI

Peisker T., Bartos A., Skoda O., Ibrahim I., Kalvach P. (2010). Impact of aging on cerebral vasoregulation and parenchymal integrity. J. Neurol. Sci. 299, 112–11510.1016/j.jns.2010.08.064 PubMed DOI

Provinciali L., Minciotti P., Ceravolo G., Angeleri F., Sanguinetti C. M. (1990). Transcranial Doppler sonography as a diagnostic tool in vascular dementia. Eur. Neurol. 30, 98–10310.1159/000117320 PubMed DOI

Pugsley W., Klinger L., Paschalis C., Treasure T., Harrison M., Newman S. (1994). The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning. Stroke 25, 1393–139910.1161/01.STR.25.7.1393 PubMed DOI

Purandare N., Burns A. (2009). Cerebral emboli in the genesis of dementia. J. Neurol. Sci. 283, 17–2010.1016/j.jns.2009.02.306 PubMed DOI

Purandare N., Burns A., Daly K. J., Hardicre J., Morris J., Macfarlane G., et al. (2006). Cerebral emboli as a potential cause of Alzheimer’s disease and vascular dementia: case-control study. BMJ 332, 1119–112410.1136/bmj.38814.696493.AE PubMed DOI PMC

Purandare N., Welsh S., Hutchinson S., Riding G., Burns A., McCollum C. (2005). Cerebral emboli and paradoxical embolisation in dementia: a pilot study. Int. J. Geriatr. Psychiatry 20, 12–1610.1002/gps.1202 PubMed DOI

Ries F., Horn R., Hillekamp J., Honisch C., Konig M., Solymosi L. (1993). Differentiation of multi-infarct and Alzheimer dementia by intracranial hemodynamic parameters. Stroke 24, 228–23510.1161/01.STR.24.2.228 PubMed DOI

Roher A. E., Garami Z., Alexandrov A. V., Kokjohn T. A., Esh C. L., Kalback W. M., et al. (2006). Interaction of cardiovascular disease and neurodegeneration: transcranial Doppler ultrasonography and Alzheimer’s disease. Neurol. Res. 28, 672–67810.1179/016164106X130470 PubMed DOI

Roher A. E., Garami Z., Tyas S. L., Maarouf C. L., Kokjohn T. A., Belohlavek M., et al. (2011). Transcranial Doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer’s disease. Alzheimers Dement. 7, 445–45510.1016/j.jalz.2010.09.002 PubMed DOI PMC

Rosengarten B., Paulsen S., Molnar S., Kaschel R., Gallhofer B., Kaps M. (2006). Acetylcholine esterase inhibitor donepezil improves dynamic cerebrovascular regulation in Alzheimer patients. J. Neurol. 253, 58–6410.1007/s00415-005-0926-5 PubMed DOI

Rosengarten B., Paulsen S., Molnar S., Kaschel R., Gallhofer B., Kaps M. (2007). Activation-flow coupling differentiates between vascular and Alzheimer type of dementia. J. Neurol. Sci. 257, 149–15410.1016/j.jns.2007.01.032 PubMed DOI

Ruitenberg A., den Heijer T., Bakker S. L., van Swieten J. C., Koudstaal P. J., Hofman A., et al. (2005). Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann. Neurol. 57, 789–79410.1002/ana.20493 PubMed DOI

Sastry S., MacNab A., Daly K., Ray S., McCollum C. (2009). Transcranial Doppler detection of venous-to-arterial circulation shunts: criteria for patent foramen ovale. J. Clin. Ultrasound 37, 276–28010.1002/jcu.20564 PubMed DOI

Schoning M., Scheel P. (1996). Color duplex measurement of cerebral blood flow volume: intra- and interobserver reproducibility and habituation to serial measurements in normal subjects. J. Cereb. Blood Flow Metab. 16, 523–53110.1097/00004647-199605000-00020 PubMed DOI

Schoning M., Walter J., Scheel P. (1994). Estimation of cerebral blood flow through color duplex sonography of the carotid and vertebral arteries in healthy adults. Stroke 25, 17–2210.1161/01.STR.25.1.17 PubMed DOI

Schreiber S. J., Doepp F., Spruth E., Kopp U. A., Valdueza J. M. (2005). Ultrasonographic measurement of cerebral blood flow, cerebral circulation time and cerebral blood volume in vascular and Alzheimer’s dementia. J. Neurol. 252, 1171–117710.1007/s00415-005-0826-8 PubMed DOI

Shah N. S., Vidal J. S., Masaki K., Petrovitch H., Ross G. W., Tilley C., et al. (2012). Midlife blood pressure, plasma beta-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study. Hypertension 59, 780–78610.1161/HYPERTENSIONAHA.111.178962 PubMed DOI PMC

Silvestrini M., Gobbi B., Pasqualetti P., Bartolini M., Baruffaldi R., Lanciotti C., et al. (2009). Carotid atherosclerosis and cognitive decline in patients with Alzheimer’s disease. Neurobiol. Aging 30, 1177–118310.1016/j.neurobiolaging.2007.11.008 PubMed DOI

Silvestrini M., Pasqualetti P., Baruffaldi R., Bartolini M., Handouk Y., Matteis M., et al. (2006). Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease. Stroke 37, 1010–101510.1161/01.STR.0000206439.62025.97 PubMed DOI

Silvestrini M., Viticchi G., Falsetti L., Balucani C., Vernieri F., Cerqua R., et al. (2011). The role of carotid atherosclerosis in Alzheimer’s disease progression. J. Alzheimers Dis. 25, 719–72610.3233/JAD-2011-101968 PubMed DOI

Society of Atherosclerosis Imaging and Prevention Developed in collaboration with the International Atherosclerosis Society (2011). Appropriate use criteria for carotid intima media thickness testing. Atherosclerosis 214, 43–4610.1016/j.atherosclerosis.2010.10.045 PubMed DOI

Stefani A., Sancesario G., Pierantozzi M., Leone G., Galati S., Hainsworth A. H., et al. (2009). CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer’s and mixed dementia. J. Neurol. Sci. 283, 109–11510.1016/j.jns.2009.02.343 PubMed DOI

Stein J. H., Korcarz C. E., Post W. S. (2009). Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: summary and discussion of the American Society of Echocardiography consensus statement. Prev. Cardiol. 12, 34–3810.1111/j.1751-7141.2008.00021.x PubMed DOI

Stoppe G., Schutze R., Kogler A., Staedt J., Munz D. L., Emrich D., et al. (1995). Cerebrovascular reactivity to acetazolamide in (senile) dementia of Alzheimer’s type: relationship to disease severity. Dementia 6, 73–82 PubMed

Sun Z. W., Zhu Y. X., Liu H. Y., Liu J., Zhu X. Q., Zhou J. N., et al. (2007). Decreased cerebral blood flow velocity in apolipoprotein E epsilon4 allele carriers with mild cognitive impairment. Eur. J. Neurol. 14, 150–15510.1111/j.1468-1331.2006.01579.x PubMed DOI

Sztriha L. K., Nemeth D., Sefcsik T., Vecsei L. (2009). Carotid stenosis and the cognitive function. J. Neurol. Sci. 283, 36–4010.1016/j.jns.2009.02.307 PubMed DOI

Teague S. M., Sharma M. K. (1991). Detection of paradoxical cerebral echo contrast embolization by transcranial Doppler ultrasound. Stroke 22, 740–74510.1161/01.STR.22.6.740 PubMed DOI

Touboul P. J., Hennerici M. G., Meairs S., Adams H., Amarenco P., Bornstein N., et al. (2012). Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc. Dis. 34, 290–29610.1159/000343145 PubMed DOI PMC

van Es A. C., van der Grond J., ten Dam V. H., de Craen A. J., Blauw G. J., Westendorp R. G., et al. (2010). Associations between total cerebral blood flow and age related changes of the brain. PLoS ONE 5:e9825.10.1371/journal.pone.0009825 PubMed DOI PMC

van Oijen M., de Jong F. J., Witteman J. C., Hofman A., Koudstaal P. J., Breteler M. M. (2007). Atherosclerosis and risk for dementia. Ann. Neurol. 61, 403–41010.1002/ana.21073 PubMed DOI

Vicenzini E., Ricciardi M. C., Altieri M., Puccinelli F., Bonaffini N., Di Piero V., et al. (2007). Cerebrovascular reactivity in degenerative and vascular dementia: a transcranial Doppler study. Eur. Neurol. 58, 84–8910.1159/000103642 PubMed DOI

Viticchi G., Falsetti L., Vernieri F., Altamura C., Bartolini M., Luzzi S., et al. (2012). Vascular predictors of cognitive decline in patients with mild cognitive impairment. Neurobiol. Aging 33, e1–e910.1016/j.neurobiolaging.2011.11.027 PubMed DOI

Wolf H., Ecke G. M., Bettin S., Dietrich J., Gertz H. J. (2000). Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study. Int. J. Geriatr. Psychiatry 15, 803–81210.1002/1099-1166(200009)15:9<803::AID-GPS190>3.3.CO;2-N PubMed DOI

Wollman D. E., Prohovnik I. (2003). Sensitivity and specificity of neuroimaging for the diagnosis of Alzheimer’s disease. Dialogues Clin. Neurosci. 5, 89–99 PubMed PMC

Wu C. C., Mungas D., Petkov C. I., Eberling J. L., Zrelak P. A., Buonocore M. H., et al. (2002). Brain structure and cognition in a community sample of elderly Latinos. Neurology 59, 383–39110.1212/WNL.59.3.383 PubMed DOI

Yamaguchi F., Meyer J. S., Yamamoto M., Sakai F., Shaw T. (1980). Noninvasive regional cerebral blood flow measurements in dementia. Arch. Neurol. 37, 410–41810.1001/archneur.1980.00500560040003 PubMed DOI

Zavoreo I., Basic Kes V., Lisak M., Marsic N., Ciliga D., Trost Bobic T. (2013). Cognitive decline and cerebral vasoreactivity in asymptomatic patients with severe internal carotid artery stenosis. Acta Neurol. Belg. 113, 453–45810.1007/s13760-013-0196-4 PubMed DOI

Vascular Cognitive Impairment: Information from Animal Models on the Pathogenic Mechanisms of Cognitive Deficits

Cognitive deficits in schizophrenia and other neuropsychiatric disorders: convergence of preclinical and clinical evidence